Gabriele Loi
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Well-being in people with HIV after one year of long-acting cabotegravir and rilpivirine.
Journal: AIDS care
Published: September 07, 2026
Impact of doxycycline post-exposure prophylaxis on Neisseria gonorrhoeae antimicrobial resistance to doxycycline and ceftriaxone in Milan, Italy.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: March 05, 2026
Two-year efficacy and safety of long-acting cabotegravir and rilpivirine in the SCohoLART study.
Journal: AIDS (London, England)
Published: February 19, 2026
Evaluating long-acting injectable HIV treatment: an update on cabotegravir and rilpivirine.
Journal: Expert review of anti-infective therapy
Published: January 08, 2026
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500 000 copies/mL in 2018-2023 in Italy: data from the ICONA Foundation Cohort Study.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: November 11, 2025
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500,000 copies/mL in 2018-2023 in Italy: data from the ICONA Foundation Cohort Study.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: November 11, 2025
A Humoral Dilemma: Reassessing Monkeypox Virus Neutralizing Antibodies at More Than 2 Years From Mpox or Modified Vaccinia Ankara-Bavarian Nordic Vaccination.
Journal: The Journal of infectious diseases
Published: September 25, 2025
Showing 1-8 of 8
Last Updated: 09/26/2026